Search - tctmd.com

Displaying 1 - 20 of 53

Sort: Relevancy | Date

News Daily News

Survey Calls Out Implicit Bias in Peripheral Vascular Care

L.A. McKeown

February 28, 2025

News Daily News

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

L.A. McKeown

December 12, 2024

News Daily News

Scientific Statement Reviews Current Antithrombotic Options in PAD

L.A. McKeown

August 26, 2024

News Daily News

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

L.A. McKeown

August 19, 2024

News Daily News

Dramatic LDL Drops Seen in PAD Patients With Team-Based Care

L.A. McKeown

June 18, 2024

News Daily News

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

L.A. McKeown

May 17, 2024

News Conference News ISET 2024

How to Reconcile BEST-CLI and BASIL-2? A ‘Patient-First’ Strategy

Caitlin E. Cox

January 24, 2024

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

News Daily News

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

L.A. McKeown

July 11, 2023

News Conference News ISET 2023

BioMimics 3D Stent Holds Up Well at 3 Years in Complex PAD Lesions

Caitlin E. Cox

January 20, 2023

News Conference News

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

L.A. McKeown

November 18, 2022

News Conference News VIVA 2022

‘Heartless’ Indifference Drives PAD/CLTI Amputations in Underserved Groups

L.A. McKeown

November 04, 2022

News Daily News

IVUS Useful in Many Peripheral Intervention Scenarios, Consensus Document

L.A. McKeown

August 05, 2022

News Opinion CV Team Dispatch

August 2022 News Roundup

L.A. McKeown

August 01, 2022

News Daily News

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

L.A. McKeown

June 29, 2022

News Opinion CV Team Dispatch

February 2022 News Roundup

L.A. McKeown

February 01, 2022

News Daily News

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

L.A. McKeown

August 10, 2021

News Conference News ACC 2021

Rivaroxaban Helps Prevent More Events Than Aspirin Alone After Leg Interventions

L.A. McKeown

May 21, 2021

News Daily News

Vascular Experts Say It’s Time to Let Paclitaxel Out of Regulatory Jail

L.A. McKeown

April 22, 2021

News Daily News

AHA Seeks to Drive Down Amputations 20% by 2030

L.A. McKeown

April 01, 2021

Advertisement

Survey Calls Out Implicit Bias in Peripheral Vascular Care

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

Scientific Statement Reviews Current Antithrombotic Options in PAD

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

Dramatic LDL Drops Seen in PAD Patients With Team-Based Care

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

How to Reconcile BEST-CLI and BASIL-2? A ‘Patient-First’ Strategy

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

BioMimics 3D Stent Holds Up Well at 3 Years in Complex PAD Lesions

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

‘Heartless’ Indifference Drives PAD/CLTI Amputations in Underserved Groups

IVUS Useful in Many Peripheral Intervention Scenarios, Consensus Document

August 2022 News Roundup

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

February 2022 News Roundup

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

Rivaroxaban Helps Prevent More Events Than Aspirin Alone After Leg Interventions

Vascular Experts Say It’s Time to Let Paclitaxel Out of Regulatory Jail

AHA Seeks to Drive Down Amputations 20% by 2030

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content